Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

Therapeutic failure of benznidazole (BZ) is widely documented in Chagas disease and has been primarily associated with variations in the drug susceptibility of Trypanosoma cruzi strains. In humans, therapeutic success has been assessed by the negativation of anti-T. cruzi antibodies, a process that...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Memorias do Instituto Oswaldo Cruz
المؤلفون الرئيسيون:	Margoth Moreno, Daniella A D'ávila, Marcelo N Silva, Lúcia MC Galvão, Andrea M Macedo, Egler Chiari, Eliane D Gontijo, Bianca Zingales
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Fundação Oswaldo Cruz (FIOCRUZ) 2010-11-01
الموضوعات:	Chagas disease benznidazole treatment drug susceptibility microsatellites
الوصول للمادة أونلاين:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762010000700014